BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 29130264)

  • 1. The Economic Cost of Communicable Disease Surveillance in Local Public Health Agencies.
    Atherly A; Whittington M; VanRaemdonck L; Lampe S
    Health Serv Res; 2017 Dec; 52 Suppl 2(Suppl 2):2343-2356. PubMed ID: 29130264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategic Methodologies in Public Health Cost Analyses.
    Whittington M; Atherly A; VanRaemdonck L; Lampe S
    J Public Health Manag Pract; 2017; 23(6):e10-e16. PubMed ID: 26910863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economies of scale in the production of public health services: an analysis of local health districts in Florida.
    Bernet PM; Singh S
    Am J Public Health; 2015 Apr; 105 Suppl 2(Suppl 2):S260-7. PubMed ID: 25689207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Famine-affected, refugee, and displaced populations: recommendations for public health issues.
    MMWR Recomm Rep; 1992 Jul; 41(RR-13):1-76. PubMed ID: 1326713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Communication Between Infectious Disease Physicians and US State and Local Public Health Agencies: Strengths, Challenges, and Opportunities.
    SantibaƱez S; Polgreen PM; Beekmann SE; Cairns C; Filice GA; Layton M; Hughes JM
    Public Health Rep; 2016 Sep; 131(5):666-670. PubMed ID: 28123206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and savings associated with community water fluoridation programs in Colorado.
    O'Connell JM; Brunson D; Anselmo T; Sullivan PW
    Prev Chronic Dis; 2005 Nov; 2 Spec no(Spec No):A06. PubMed ID: 16263039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the cost to U.S. health departments to conduct HIV surveillance.
    Shrestha RK; Sansom SL; Laffoon BT; Farnham PG; Shouse RL; MacMaster K; Hall HI
    Public Health Rep; 2014; 129(6):496-504. PubMed ID: 25364051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social and economic impact of infectious diseases--United States.
    Larson E
    Clin Perform Qual Health Care; 1997; 5(1):31-7. PubMed ID: 10164997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Too Big, Too Small, or Just Right? Cost-Efficiency of Environmental Inspection Services in Connecticut.
    Cohen JP; Checko PJ
    Health Serv Res; 2017 Dec; 52 Suppl 2(Suppl 2):2285-2306. PubMed ID: 28726250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic crisis and communicable disease control in Europe: a scoping study among national experts.
    Rechel B; Suhrcke M; Tsolova S; Suk JE; Desai M; McKee M; Stuckler D; Abubakar I; Hunter P; Senek M; Semenza JC
    Health Policy; 2011 Dec; 103(2-3):168-75. PubMed ID: 21820196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timeliness in the German surveillance system for infectious diseases: Amendment of the infection protection act in 2013 decreased local reporting time to 1 day.
    Schumacher J; Diercke M; Salmon M; Czogiel I; Schumacher D; Claus H; Gilsdorf A
    PLoS One; 2017; 12(10):e0187037. PubMed ID: 29088243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An empirical study of economies of scope in home healthcare.
    Gonzales TI
    Health Serv Res; 1997 Aug; 32(3):313-24. PubMed ID: 9240283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Communicable-disease surveillance in New Jersey.
    Bednarczyk M; Lu S; Tan CG; Bresnitz EA
    N J Med; 2004 Sep; 101(9 Suppl):45-50; quiz 50-2. PubMed ID: 15497734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance for waterborne-disease outbreaks--United States, 1999-2000.
    Lee SH; Levy DA; Craun GF; Beach MJ; Calderon RL
    MMWR Surveill Summ; 2002 Nov; 51(8):1-47. PubMed ID: 12489843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Communicable disease case entry using PDAs and public wireless networks.
    Lober WB; Bliss D; Dockrey MR; Davidson AJ; Karras BT
    AMIA Annu Symp Proc; 2003; 2003():916. PubMed ID: 14728422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scenarios, personas and user stories: user-centered evidence-based design representations of communicable disease investigations.
    Turner AM; Reeder B; Ramey J
    J Biomed Inform; 2013 Aug; 46(4):575-84. PubMed ID: 23618996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [General practitioners and mandatory surveillance of communicable diseases: a descriptive study in Puglia (South Italy)].
    Prato R; Napoli C; Barbuti G; Germinario C; Lopalco PL
    Ann Ig; 2004; 16(3):449-55. PubMed ID: 15368936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leveraging social networking sites for disease surveillance and public sensing: the case of the 2013 avian influenza A(H7N9) outbreak in China.
    Zhang EX; Yang Y; Di Shang R; Simons JJ; Quek BK; Yin XF; See W; Oh OS; Nandar KS; Ling VR; Chan PP; Wang Z; Goh RS; James L; Tey JS
    Western Pac Surveill Response J; 2015; 6(2):66-72. PubMed ID: 26306219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public Health Surveillance for Communicable Diseases: From Rigid and Static to Flexible and Innovative.
    Heymann DL
    Am J Public Health; 2017 Jun; 107(6):845-846. PubMed ID: 28498757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.